Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients
NCT03038451
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet
Sponsor
Neutec Ar-Ge San ve Tic A.Ş